Health Catalyst, Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Health Catalyst, Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • Health Catalyst, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 102 %, a 22.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 102 +18.6 +22.2% Sep 30, 2024
Q2 2024 91.4 +10.5 +12.9% Jun 30, 2024
Q1 2024 89.3 +11.5 +14.8% Mar 31, 2024
Q4 2023 87.1 +12.8 +17.2% Dec 31, 2023
Q3 2023 83.5 +13.8 +19.8% Sep 30, 2023
Q2 2023 81 +17 +26.6% Jun 30, 2023
Q1 2023 77.8 +10.1 +14.9% Mar 31, 2023
Q4 2022 74.4 +0.38 +0.51% Dec 31, 2022
Q3 2022 69.7 -17 -19.6% Sep 30, 2022
Q2 2022 64 -39.8 -38.3% Jun 30, 2022
Q1 2022 67.7 -35 -34.1% Mar 31, 2022
Q4 2021 74 -15.8 -17.6% Dec 31, 2021
Q3 2021 86.7 +11 +14.6% Sep 30, 2021
Q2 2021 104 +38.4 +58.8% Jun 30, 2021
Q1 2021 103 -695 -87.1% Mar 31, 2021
Q4 2020 89.7 Dec 31, 2020
Q3 2020 75.7 Sep 30, 2020
Q2 2020 65.3 Jun 30, 2020
Q1 2020 798 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.